Progesterone dose during synchronization treatment alters luteinizing hormone receptor and steroidogenic enzyme mRNA abundances in granulosa cells of Nellore heifers

Anim Reprod Sci. 2021 Feb:225:106681. doi: 10.1016/j.anireprosci.2020.106681. Epub 2020 Dec 16.

Abstract

The objective was to investigate effects of progesterone (P4) dose on abundance of luteinizing hormone receptor (LHCGR), aromatase (CYP19A1), 3β-hydroxysteroid dehydrogenase (HSD3B1), and other steroidogenic mRNA transcripts in granulosa cells from dominant follicles. Nellore heifers were assigned to one of six groups: new, first-use controlled internal drug release device (CIDR1) inserted for 5 days (Large-P4-dose-D5; n = 7) or 6 days (Large-P4-dose-D6; n = 8), prostaglandin (PG)F administered on D0 and 1 previously-used CIDR (CIDR3) inserted for 5 days (Small- P4-dose-D5; n = 8) or 6 days (Small-P4-dose-D6; n = 8), CIDR1 inserted on D0 and removed plus PGF on D5 (Large-P4-dose-proestrus (PE); n = 7), and CIDR3 and PGF on D0 and 1, CIDR3 removed plus PGF on D5 (Small-P4-dose-PE; n = 7). Duration of P4 treatment (D5 compared to D6) affected abundances of CYP19A1 mRNA transcripts, with there being greater abundances on D6 than D5 (P ≤ 0.05). Heifers treated with the large dose of P4 had a smaller dominant follicle, less serum and intra-follicular estradiol (E2) concentrations (P ≤ 0.05) and lesser LHCGR, CYP19A1, and HSD3B1 transcript abundances (P ≤ 0.05). Heifers treated to induce PE had a larger follicle diameter (P = 0.09), greater intra-follicular E2 concentrations and larger abundances of CYP19A1 mRNA transcript (P ≤ 0.05) than heifers of the D6 group. Overall, treatment with larger doses of P4 resulted in lesser abundances of LHCGR, HSD3B1, and CYP19A1 mRNA transcripts; thus, potentially leading to development of smaller dominant follicles and lesser E2 concentrations.

Keywords: Granulosa cell; LH receptor; Nellore heifers; Progesterone.

MeSH terms

  • Animals
  • Aromatase / genetics
  • Aromatase / metabolism
  • Cattle*
  • Cholesterol Side-Chain Cleavage Enzyme / genetics
  • Cholesterol Side-Chain Cleavage Enzyme / metabolism
  • Dinoprost / administration & dosage
  • Dinoprost / analogs & derivatives
  • Dinoprost / pharmacology
  • Estradiol / administration & dosage
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Estrus Synchronization / drug effects*
  • Female
  • Gene Expression Regulation / drug effects
  • Granulosa Cells / drug effects
  • Multienzyme Complexes / genetics
  • Multienzyme Complexes / metabolism
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism
  • Progesterone / administration & dosage
  • Progesterone / pharmacology*
  • Progesterone Reductase / genetics
  • Progesterone Reductase / metabolism
  • Receptors, LH / genetics
  • Receptors, LH / metabolism*
  • Steroid Isomerases / genetics
  • Steroid Isomerases / metabolism

Substances

  • 3 beta-hydroxysteroid oxidoreductase-delta(5) 3-ketosteroid isomerase
  • Multienzyme Complexes
  • Phosphoproteins
  • Receptors, LH
  • steroidogenic acute regulatory protein
  • estradiol 3-benzoate
  • Progesterone
  • Estradiol
  • estradiol 17 beta-cypionate
  • Dinoprost
  • dinoprost tromethamine
  • Progesterone Reductase
  • Aromatase
  • Cholesterol Side-Chain Cleavage Enzyme
  • Steroid Isomerases